Dynamics of prescription drug use, diagnoses and health care utilization after community managed SARS-CoV-2 infection

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS37658
• Study ID:
  41235
• Official title and acronym:
  Dynamics of prescription drug use, diagnoses and health care utilization after community managed SARS-CoV-2 infection
• DARWIN EU® study:
  No
• Study countries:
  Denmark
• Study description:
  Using the Danish national health registries, we examine drug use, hospital diagnoses and health care utilization prior to and after SARS-CoV-2 infection among individuals with community managed SARS-CoV-2 infection. Analyses are repeated for an age and sex matched cohort of individuals tested negative for SARS-CoV-2 and individuals hospitalized with SARS-CoV-2 infection.
• Study status:
  Finalised

Research institutions and networks

Institutions

Pharmacoepi center, University of Southern Denmark

Denmark

Study timelines

Date when funding contract was signed

Planned:01/10/2020

Actual:01/10/2020

Study start date

Planned:27/02/2020

Actual:27/02/2020

Data analysis start date

Planned:20/10/2020

Actual:20/10/2020

Date of final study report

Planned:15/11/2020

Actual:10/05/2021

Sources of funding

Other

More details on funding

University of Southern Denmark

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable